These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 15155534

  • 1. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
    Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM.
    Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
    [Abstract] [Full Text] [Related]

  • 2. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
    Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM.
    Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
    [Abstract] [Full Text] [Related]

  • 3. Cannabinoid WIN 55,212-2 inhibits TRPV1 in trigeminal ganglion neurons via PKA and PKC pathways.
    Wang W, Cao X, Liu C, Liu L.
    Neurol Sci; 2012 Feb; 33(1):79-85. PubMed ID: 21584737
    [Abstract] [Full Text] [Related]

  • 4. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat.
    Bereiter DA, Bereiter DF, Hirata H.
    Pain; 2002 Oct; 99(3):547-556. PubMed ID: 12406531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord.
    Milne M, Ashton JC.
    Neurosci Lett; 2016 Feb 12; 614():39-42. PubMed ID: 26762784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
    Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A.
    Glia; 2003 Jan 15; 41(2):161-8. PubMed ID: 12509806
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D, Almado CE, Dagostin AL, Machado BH, Leão RM.
    Brain Res; 2008 Mar 20; 1200():1-9. PubMed ID: 18308297
    [Abstract] [Full Text] [Related]

  • 10. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.
    Ellington HC, Cotter MA, Cameron NE, Ross RA.
    Neuropharmacology; 2002 Jun 20; 42(7):966-75. PubMed ID: 12069907
    [Abstract] [Full Text] [Related]

  • 11. Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons.
    Papanastassiou AM, Fields HL, Meng ID.
    Pain; 2004 Feb 20; 107(3):267-275. PubMed ID: 14736589
    [Abstract] [Full Text] [Related]

  • 12. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ, Wu HJ, Wang SY, Yin S, Lu XJ, Miao Y, Wang XH, Yang XL, Wang Z.
    Neuroscience; 2013 Dec 03; 253():183-93. PubMed ID: 24013008
    [Abstract] [Full Text] [Related]

  • 13. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
    Hoffman AF, Lupica CR.
    J Neurophysiol; 2001 Jan 03; 85(1):72-83. PubMed ID: 11152707
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons.
    Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM.
    J Biol Chem; 2006 Oct 27; 281(43):32879-90. PubMed ID: 16954222
    [Abstract] [Full Text] [Related]

  • 15. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
    Ahluwalia J, Urban L, Bevan S, Nagy I.
    Eur J Neurosci; 2003 Jun 27; 17(12):2611-8. PubMed ID: 12823468
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
    Scholl A, Ivanov I, Hinz B.
    Oncotarget; 2016 Sep 20; 7(38):61438-61457. PubMed ID: 27556861
    [Abstract] [Full Text] [Related]

  • 17. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
    Johanek LM, Heitmiller DR, Turner M, Nader N, Hodges J, Simone DA.
    Pain; 2001 Sep 20; 93(3):303-315. PubMed ID: 11514089
    [Abstract] [Full Text] [Related]

  • 18. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM, Simone DA.
    Pain; 2004 Jun 20; 109(3):432-442. PubMed ID: 15157704
    [Abstract] [Full Text] [Related]

  • 19. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC, Lo SW, Hsu KS.
    J Physiol; 2001 May 01; 532(Pt 3):731-48. PubMed ID: 11313442
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
    Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan 01; 361(1):19-24. PubMed ID: 10651142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.